Chromosome Analysis Leukemic Peripheral Blood (Oncology)
Expected Turnaround Time
7 days
Stated turn-around-times (TATs) are for clinical use only and subject to change based on biopharma protocol requirements. Final TATs will be specified in the biopharma study contract.
Stated turn-around-times (TATs) are for clinical use only and subject to change based on biopharma protocol requirements. Final TATs will be specified in the biopharma study contract.
Clinical Information
Chromosome analysis on peripheral blood samples suspected of harboring a hematologic disorder. Note: This test should only be ordered if bone marrow is not available for testing.
Requisition Forms
Specimen Requirements
Specimen Requirements
Whole Blood: 5 mL, EDTA preferred (NaHep accepted)
Specimen Stability
72 Hour
Storage Requirements
- Whole Blood: 2°C to 25°C
- Fixed Cytogenetically Prepared Cells: -28°C to -15°C
Shipping Recommendations
AMBIENT, Use a refrigerated (NOT FROZEN) gel pack in the shipment to protect from extreme temperatures. Separate gel pack from specimen. Do not freeze.
Specimen Rejection Criteria
Clotted specimen; Specimen exposed to extreme temperature; Anticoagulant toxic to cells; Insufficient number of cells
Test Details
Synonyms
Chromosome analysis, cytogenetic analysis, karyotyping, G-banding
Keywords
Cytogenetics, Leukemia, Oncology, Oncology Cytogenetics, Karyotyping
Test Method
Karyotyping
Methodology Category
Cytogenetics
Regulatory Status
RUO
Special Considerations
All attempts will be made to process and report samples received > 72 hours post-collection. Bone marrow is the sample of choice in most heme malignancies.
Associations
Leukemia